Movement Alert｜Joinn Laboratories Rises 5.08% in Regular Trading, Barclays Stake Increase Coupled with CXO Sector Strength

Market Focus

07/22

On July 22, Joinn Laboratories (06127.HK) rose 5.08% in regular trading, trading at 26.32 HKD/share, with turnover of 106 million HKD.

On the news front, Hong Kong Exchange equity disclosures revealed that Barclays PLC acquired approximately 3.28 million shares of Joinn Laboratories on July 15 at an average price of 24.25 HKD per share, totaling approximately 79.54 million HKD. Following the purchase, Barclays' stake rose to 6.12%. The institutional accumulation signals growing confidence in the company's valuation.

Additionally, the broader CXO sector continued its rebound momentum, providing further support. Within the Life Sciences Tools and Services sector, WuXi AppTec gained 3.47%, WuXi Biologics rose 2.63%, Insilico surged 7.14%, Pharmaron climbed 6.44%, and GenScript Biotech added 3.41%, reflecting broad-based sector recovery.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hant/news/1124586548"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1124586548\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1124586548?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-22 09:55","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1124586548","market":"us","top_or_hot":-1,"title":"Movement Alert｜Joinn Laboratories Rises 5.08% in Regular Trading, Barclays Stake Increase Coupled with CXO Sector Strength","media":"Market Focus","content":"<p><p>On July 22, Joinn Laboratories (06127.HK) rose 5.08% in regular trading, trading at 26.32 HKD/share, with turnover of 106 million HKD.</p><p>On the news front, Hong Kong Exchange equity disclosures revealed that Barclays PLC acquired approximately 3.28 million shares of Joinn Laboratories on July 15 at an average price of 24.25 HKD per share, totaling approximately 79.54 million HKD. Following the purchase, Barclays' stake rose to 6.12%. The institutional accumulation signals growing confidence in the company's valuation.</p><p>Additionally, the broader CXO sector continued its rebound momentum, providing further support. Within the Life Sciences Tools and Services sector, WuXi AppTec gained 3.47%, WuXi Biologics rose 2.63%, Insilico surged 7.14%, Pharmaron climbed 6.44%, and GenScript Biotech added 3.41%, reflecting broad-based sector recovery.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜Joinn Laboratories Rises 5.08% in Regular Trading, Barclays Stake Increase Coupled with CXO Sector Strength</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜Joinn Laboratories Rises 5.08% in Regular Trading, Barclays Stake Increase Coupled with CXO Sector Strength\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time smaller\">2026-07-22 09:55</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p><p>On July 22, Joinn Laboratories (06127.HK) rose 5.08% in regular trading, trading at 26.32 HKD/share, with turnover of 106 million HKD.</p><p>On the news front, Hong Kong Exchange equity disclosures revealed that Barclays PLC acquired approximately 3.28 million shares of Joinn Laboratories on July 15 at an average price of 24.25 HKD per share, totaling approximately 79.54 million HKD. Following the purchase, Barclays' stake rose to 6.12%. The institutional accumulation signals growing confidence in the company's valuation.</p><p>Additionally, the broader CXO sector continued its rebound momentum, providing further support. Within the Life Sciences Tools and Services sector, WuXi AppTec gained 3.47%, WuXi Biologics rose 2.63%, Insilico surged 7.14%, Pharmaron climbed 6.44%, and GenScript Biotech added 3.41%, reflecting broad-based sector recovery.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"06127","symbol_name":"昭衍新藥","start_time":0,"source_url":"","article_id":"1124586548","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1124586548","pubTimestamp":1784685322,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On July 22, Joinn Laboratories (06127.HK) rose 5.08% in regular trading, trading at 26.32 HKD/share, with turnover of 106 million HKD.On the news front, Hong Kong Exchange equity disclosures revealed...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"06127":"昭衍新药"},"translate_title":"走势警报|Joinn Laboratories 常规交易中上涨 5.08%，巴克莱增持股份加上 CXO 板块走强","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"06127":1},"content_text":"On July 22, Joinn Laboratories (06127.HK) rose 5.08% in regular trading, trading at 26.32 HKD/share, with turnover of 106 million HKD.On the news front, Hong Kong Exchange equity disclosures revealed that Barclays PLC acquired approximately 3.28 million shares of Joinn Laboratories on July 15 at an average price of 24.25 HKD per share, totaling approximately 79.54 million HKD. Following the purchase, Barclays' stake rose to 6.12%. The institutional accumulation signals growing confidence in the company's valuation.Additionally, the broader CXO sector continued its rebound momentum, providing further support. Within the Life Sciences Tools and Services sector, WuXi AppTec gained 3.47%, WuXi Biologics rose 2.63%, Insilico surged 7.14%, Pharmaron climbed 6.44%, and GenScript Biotech added 3.41%, reflecting broad-based sector recovery.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}